CD38 and neoplasm: The binding of naked moAbs to CD38 exerts tumor killing by multiple mechanism including direct apoptosis and activation of potent cytotoxic immune effector functions, such as antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytotoxicity (CDC) [6], (Figure 1).